Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-09

Clinical Trial Update: HRQoL Keratinocyte Carcinomas

View source ↗

Summary

A clinical trial at University Hospital Ghent is enrolling by invitation to assess health-related quality of life in patients with keratinocyte carcinomas, incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Ghent | Conditions: Basal Cell Carcinoma, Squamous Cell Carcinoma | Status: ENROLLING_BY_INVITATION